Works matching IS 15747891 AND DT 2022 AND VI 16 AND IP 20

Results: 10

Prognostic value of baseline genetic features and newly identified TP53 mutations in advanced breast cancer.

Published in:

Molecular Oncology, 2022, v. 16, n. 20, p. 3689, doi. 10.1002/1878-0261.13297

By:

Lanxin Zhang;
Siwen Sun;
Xiaotian Zhao;
Jingwen Liu;
Yang Xu;
Lingzhi Xu;
Chen Song;
Na Li;
Jing Yu;
Shanshan Zhao;
Peiyao Yu;
Fengqi Fang;
Jiping Xie;
Xuening Ji;
Ruoying Yu;
Qiuxiang Ou;
Zuowei Zhao;
Man Li

Publication type:

Article

Profiling of extracellular vesicles of metastatic urothelial cancer patients to discover protein signatures related to treatment outcome.

Published in:

Molecular Oncology, 2022, v. 16, n. 20, p. 3620, doi. 10.1002/1878-0261.13288

By:

Viktorsson, Kristina;
Hååg, Petra;
Shah, Carl-Henrik;
Franzén, Bo;
Arapi, Vasiliki;
Holmsten, Karin;
Sandström, Per;
Lewensohn, Rolf;
Ullé, Anders

Publication type:

Article

Apatinib enhances chemosensitivity of ABT-199 in diffuse large B-cell lymphoma.

Published in:

Molecular Oncology, 2022, v. 16, n. 20, p. 3735, doi. 10.1002/1878-0261.13309

By:

Yuanfei Shi;
Jing Ye;
Huafei Shen;
Yi Xu;
Rui Wan;
Xiujin Ye;
Jie Jin;
Wanzhuo Xie

Publication type:

Article

IL-7 is expressed in malignant mesothelioma and has a prognostic value.

Published in:

Molecular Oncology, 2022, v. 16, n. 20, p. 3606, doi. 10.1002/1878-0261.13310

By:

Hoa-Le Mai;
Deshayes, Sophie;
Thi-Van-Ha Nguyen;
Dehame, Virginie;
Chéné, Anne-Laure;
Brouard, Sophie;
Blanquart, Christophe

Publication type:

Article

Growth arrest-specific protein 2 (GAS2) interacts with CXCR4 to promote T-cell leukemogenesis partially via c-MYC.

Published in:

Molecular Oncology, 2022, v. 16, n. 20, p. 3720, doi. 10.1002/1878-0261.13306

By:

Wenjuan Ma;
Yan Wan;
Jianxiang Zhang;
Jianan Yao;
Yifei Wang;
Jinchang Lu;
Hong Liu;
Xiaorui Huang;
Xiuyan Zhang;
Haixia Zhou;
Yulong He;
Depei Wu;
Jianrong Wang;
Yun Zhao

Publication type:

Article

Identification and targeting of a HES1-YAP1-CDKN1C functional interaction in fusion-negative rhabdomyosarcoma.

Published in:

Molecular Oncology, 2022, v. 16, n. 20, p. 3587, doi. 10.1002/1878-0261.13304

By:

Kovach, Alexander R.;
Oristian, Kristianne M.;
Kirsch, David G.;
Bentley, Rex C.;
Changde Cheng;
Xiang Chen;
Po-Han Chen;
Chi, Jen-Tsan Ashley;
Linardic, Corinne M.

Publication type:

Article

Comparing single-target and multitarget approaches for postoperative circulating tumour DNA detection in stage II–III colorectal cancer patients.

Published in:

Molecular Oncology, 2022, v. 16, n. 20, p. 3654, doi. 10.1002/1878-0261.13294

By:

Henriksen, Tenna Vesterman;
Reinert, Thomas;
Rasmussen, Mads Heilskov;
Demuth, Christina;
Løve, Uffe Schou;
Madsen, Anders Husted;
Gotschalck, Kåre Andersson;
Iversen, Lene Hjerrild;
Andersen, Claus Lindbjerg

Publication type:

Article

Analysis of genetic profiling, pathomics signature, and prognostic features of primary lymphoepithelioma-like carcinoma of the renal pelvis.

Published in:

Molecular Oncology, 2022, v. 16, n. 20, p. 3666, doi. 10.1002/1878-0261.13307

By:

Bo Fan;
Yuanbin Huang;
Hongshuo Zhang;
Tingyu Chen;
Shenghua Tao;
Xiaogang Wang;
Shuang Wen;
Honglong Wang;
Zhe Lin;
Tianqing Liu;
Hongxian Zhang;
Tao He;
Xiancheng Li

Publication type:

Article

Loss of GABARAPL1 confers ferroptosis resistance to cancer stem-like cells in hepatocellular carcinoma.

Published in:

Molecular Oncology, 2022, v. 16, n. 20, p. 3703, doi. 10.1002/1878-0261.13305

By:

Xiaojing Du;
Zhuoran Qi;
Jinzhi Xu;
Mengzhou Guo;
Xingxing Zhang;
Zhijie Yu;
Xin Cao;
Jinglin Xia

Publication type:

Article

Sphingosine-1-phosphate-lyase deficiency affects glucose metabolism in a way that abets oncogenesis.

Published in:

Molecular Oncology, 2022, v. 16, n. 20, p. 3642, doi. 10.1002/1878-0261.13300

By:

Afsar, Sumaiya Y.;
Alam, Shah;
Fernandez Gonzalez, Carina;
van Echten-Deckert, Gerhild

Publication type:

Article